Inicio › Enfermedad de obstrucción pulmonar crónica › Pensilvania
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Pensilvania
33 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en Pensilvania.
Ciudades en Pensilvania
Texto oficial del estudio (inglés)
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50002, DuBois
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07725939A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Clinical Research Associates of Central PA, DuBois
ReclutandoFase 2
Edades de 40 a 75 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07759245Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Penn Highlands - Lung Innovations/Clinical Research Associates, DuBois
- Temple University - Temple Lung Center, Philadelphia
- University of Pittsburgh Medical Center - UMPC Comprehensive Lung Center, Pittsburgh
Reclutando
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07051707WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
- Temple University Hospital, Philadelphia
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07558265To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Clinical Research Associates of Central PA, LLC, DuBois
- DM Clinical Research - Philadelphia, Philadelphia
ReclutandoFase 2
Edades de 40 a 85 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07684820A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Camp Hill
- Research Site, DuBois
- Research Site, Philadelphia
- y 3 más
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Suburban Research Associates - Media- Site Number : 8400143, Media
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07190222A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, DuBois
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07646587A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Clinical Research Associates of Central PA, LLC, DuBois
- Temple University Hospital, Philadelphia
- Temple Health Oaks, Phoenixville
ReclutandoFase 2/3
Edades de 35 a 80 · Todos los sexos · Actualizado el 22 oct 2026 · NCT07363694A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Clinical Research Associates of Central Pennsylvania- Site Number : 8400002, DuBois
ReclutandoFase 4
Edades de 40 a 85 · Todos los sexos · Actualizado el 20 oct 2026 · NCT07053423Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Clinical Research Associates of Central Pennsylvania, DuBois
- Temple University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
Reclutando
Edades de 40 a 84 · Todos los sexos · Actualizado el 19 oct 2026 · NCT06891755Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Temple University Hospital- Site Number : 8400059, Philadelphia
- Preferred Primary Care Physicians - Pleasant Hills- Site Number : 8400092, Pittsburgh
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 19 oct 2026 · NCT07190209STRIVE Post-Market Registry Study
- Penn State Milton S. Hershey Medical Center, Hershey
- Temple University, Philadelphia
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT04302272A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Horsham
- Research Site, Pittsburgh
- Research Site, Sayre
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 9 oct 2026 · NCT06878261Emphysema Research Registry and Biosample Repository
- University of Pittsburgh Emphysema/COPD Research Center, Pittsburgh
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 21 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT00307281Acoustic Waveform Respiratory Evaluation
- University of Pittsburgh, Pittsburgh
ReclutandoSe aceptan voluntarios sanos
Edades de 8 a 70 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06512064Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06961214A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Camp Hill
- Research Site, Philadelphia
- Research Site, Philadelphia
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 2 oct 2026 · NCT06283966An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Penn Medicine, Philadelphia
- Temple University, Philadelphia
- Allegheny General Hospital, Pittsburgh
- y 1 más
Reclutando
Edades de 40 a 80 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06035120Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Temple University, Philadelphia
- University of Pittsburgh, Pittsburgh
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, DuBois
- Research Site, Philadelphia
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06883305COPD Exacerbation Follow Up
- Thomas Jefferson University, Philadelphia
ReclutandoEstudio observacional
Edades de 40 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07118306Multi-Center Clean Air Randomized Controlled Trial in COPD
- Reading Hospital, West Reading
ReclutandoFase 3
Edades de 40 en adelante · Todos los sexos · Actualizado el 31 jul 2026 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, DuBois
- GSK Investigational Site, West Chester
ReclutandoFase 3
Edades de 40 a 75 · Todos los sexos · Actualizado el 28 jul 2026 · NCT07177339Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- Temple University Hospital, Philadelphia
Reclutando
Edades de 22 en adelante · Todos los sexos · Actualizado el 23 jun 2026 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- Temple University, Philadelphia
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 30 a 55 · Todos los sexos · Actualizado el 3 jun 2026 · NCT05033990Feasibility of Semaglutide in Advanced Lung Disease
- University of Pennsylvania Perelman School of Medicine, Philadelphia
ReclutandoFase 1/2
Edades de 18 a 80 · Todos los sexos · Actualizado el 21 abr 2026 · NCT05746039Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
- Thomas Jefferson University, Philadelphia
ReclutandoEstudio observacional
Edades de 50 a 80 · Todos los sexos · Actualizado el 3 mar 2026 · NCT06974981Supporting Evidence-based Responses to Emotional Needs in Emphysema
- University of Pennsylvania, Philadelphia
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 ene 2026 · NCT06600126Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
- UPMC Presbyterian, Pittsburgh
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
ReclutandoFase 1/2
Edades de 18 a 60 · Todos los sexos · Actualizado el 13 ene 2026 · NCT03500731Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Clinical Research Associates of Central PA, DuBois
- US Digestive Health at Lancaster, Lancaster
- Temple University, Philadelphia
- y 2 más
ReclutandoEstudio observacional
Edades de 50 en adelante · Todos los sexos · Actualizado el 5 ago 2025 · NCT06122077Temple Health Chest Initiative (THCI 2.0)
- Temple University Of the Commonwealth System of Higher Education, Philadelphia
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 50 a 80 · Todos los sexos · Actualizado el 18 abr 2025 · NCT06933758myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- St. Luke's University Health Network, Bethlehem
- Clinical Research Associates of Central Pennsylvania, DuBois
- Jeanes Hospital, Philadelphia
- y 2 más
Reclutando
Edades de 30 en adelante · Todos los sexos · Actualizado el 6 feb 2025 · NCT05204888De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.